Show simple item record

dc.contributor.authorEngin, Aynur
dc.contributor.authorElaldi, Nazif
dc.contributor.authorDokmetas, Ilyas
dc.contributor.authorBakici, Mustafa Zahir
dc.contributor.authorKaya, Safak
dc.contributor.authorBakir, Mehmet
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T10:13:42Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T10:13:42Z
dc.date.issued2010
dc.identifier.issn1300-0292
dc.identifier.urihttps://dx.doi.org/10.5336/medsci.2008-10330
dc.identifier.urihttps://hdl.handle.net/20.500.12418/9879
dc.descriptionWOS: 000281262200028en_US
dc.description.abstractObjective: Anthrax is a zoonotic infectious disease that caused by Bacillus anthracis. Sporadic anthrax is still present world-wide, particularly in animal raising countries including Turkey. The aim of this study was to evaluate the epidemiological, clinical, and laboratory findings and treatment protocols of adult patients with cutaneous anthrax retrospectively. Material and Methods: A retrospective review of 39 adult patients with cutaneous anthrax presented between 1983 and 2005, in Cumhuriyet University Hospital in Sivas, a city located in the central Anatolia region of Turkey was carried out. Results: Of the 39 cases with the diagnosis of cutaneous anthrax, 27 (69.2%) were males and 12 (30.8%) were females. The mean age was 44 (range, 1674) years. The clinical presentations were severe edema due to anthrax in 10 (26%) and typical pustuler lesion in 29 (74%) patients. The lesions were mostly located on the hand and forearm. Twenty-five cases (64.1%) had a history of recent animal slaughtering activity. Culturing of 39 wound specimens yielded 17 (43.6%) B. anthracis strains. Thirty-six (92.3%) patients were treated with penicillin G. A patient with severe cutaneous anthrax and extensive edema died on the first admission day. Mortality rate was 2.6%. Conclusion: Although the incidence of anthrax is decreasing world-wide, it is still encountered in Turkey. Preventive measures such as education of the risk population and vaccinaton of animals against anthrax would reduce the incidence of the disease. We suppose that penicillin is still the antibiotic of choice for the treatment of cutaneous anthrax in endemic regions.en_US
dc.language.isoengen_US
dc.publisherORTADOGU AD PRES & PUBL COen_US
dc.relation.isversionof10.5336/medsci.2008-10330en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAnthraxen_US
dc.subjectclinical trialen_US
dc.subjecttherapyen_US
dc.subjectTurkeyen_US
dc.titleCutaneous Anthrax in the Central Anatolia Region of Turkey: A Review of 39 Adults Casesen_US
dc.typereviewen_US
dc.relation.journalTURKIYE KLINIKLERI TIP BILIMLERI DERGISIen_US
dc.contributor.department[Engin, Aynur -- Elaldi, Nazif -- Dokmetas, Ilyas -- Bakir, Mehmet] Cumhuriyet Univ, Fac Med, Dept Infect Dis & Clin Microbiol, Sivas, Turkey -- [Bakici, Mustafa Zahir] Cumhuriyet Univ, Fac Med, Dept Microbiol & Clin Microbiol, Sivas, Turkey -- [Kaya, Safak] Cankiri State Hosp, Infect Dis Clin, Cankiri, Turkeyen_US
dc.contributor.authorIDElaldi, Nazif -- 0000-0002-9515-770X; dokmetas, ilyas -- 0000-0003-3523-3923en_US
dc.identifier.volume30en_US
dc.identifier.issue3en_US
dc.identifier.endpage1038en_US
dc.identifier.startpage1032en_US
dc.relation.publicationcategoryDiğeren_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record